Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis

Abstract Atherosclerosis, the major cause of cardiovascular disease, is a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells in the artery wall. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the progre...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto Canfrán‐Duque, Noemi Rotllan, Xinbo Zhang, Marta Fernández‐Fuertes, Cristina Ramírez‐Hidalgo, Elisa Araldi, Lidia Daimiel, Rebeca Busto, Carlos Fernández‐Hernando, Yajaira Suárez
Format: Article
Language:English
Published: Springer Nature 2017-07-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201607492
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332322270183424
author Alberto Canfrán‐Duque
Noemi Rotllan
Xinbo Zhang
Marta Fernández‐Fuertes
Cristina Ramírez‐Hidalgo
Elisa Araldi
Lidia Daimiel
Rebeca Busto
Carlos Fernández‐Hernando
Yajaira Suárez
author_facet Alberto Canfrán‐Duque
Noemi Rotllan
Xinbo Zhang
Marta Fernández‐Fuertes
Cristina Ramírez‐Hidalgo
Elisa Araldi
Lidia Daimiel
Rebeca Busto
Carlos Fernández‐Hernando
Yajaira Suárez
author_sort Alberto Canfrán‐Duque
collection DOAJ
description Abstract Atherosclerosis, the major cause of cardiovascular disease, is a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells in the artery wall. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the progression of atherosclerosis. Here, we define the contribution of miR‐21 in hematopoietic cells during atherogenesis. Interestingly, we found that miR‐21 is the most abundant miRNA in macrophages and its absence results in accelerated atherosclerosis, plaque necrosis, and vascular inflammation. miR‐21 expression influences foam cell formation, sensitivity to ER‐stress‐induced apoptosis, and phagocytic clearance capacity. Mechanistically, we discovered that the absence of miR‐21 in macrophages increases the expression of the miR‐21 target gene, MKK3, promoting the induction of p38‐CHOP and JNK signaling. Both pathways enhance macrophage apoptosis and promote the post‐translational degradation of ABCG1, a transporter that regulates cholesterol efflux in macrophages. Altogether, these findings reveal a major role for hematopoietic miR‐21 in atherogenesis.
format Article
id doaj-art-9c10e68c45eb4231aed7f8eaef9ae744
institution Kabale University
issn 1757-4676
1757-4684
language English
publishDate 2017-07-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-9c10e68c45eb4231aed7f8eaef9ae7442025-08-20T03:46:13ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842017-07-01991244126210.15252/emmm.201607492Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesisAlberto Canfrán‐Duque0Noemi Rotllan1Xinbo Zhang2Marta Fernández‐Fuertes3Cristina Ramírez‐Hidalgo4Elisa Araldi5Lidia Daimiel6Rebeca Busto7Carlos Fernández‐Hernando8Yajaira Suárez9Vascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineServicio de Bioquímica‐Investigación, Hospital Universitario Ramón y Cajal de Investigación Sanitaria (IRyCIS)Vascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineVascular Biology and Therapeutics Program, Integrative Cell Signaling and Neurobiology of Metabolism Program and the Departments of Comparative Medicine and Pathology, Yale University School of MedicineAbstract Atherosclerosis, the major cause of cardiovascular disease, is a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells in the artery wall. Aberrant expression of microRNAs has been implicated in the pathophysiological processes underlying the progression of atherosclerosis. Here, we define the contribution of miR‐21 in hematopoietic cells during atherogenesis. Interestingly, we found that miR‐21 is the most abundant miRNA in macrophages and its absence results in accelerated atherosclerosis, plaque necrosis, and vascular inflammation. miR‐21 expression influences foam cell formation, sensitivity to ER‐stress‐induced apoptosis, and phagocytic clearance capacity. Mechanistically, we discovered that the absence of miR‐21 in macrophages increases the expression of the miR‐21 target gene, MKK3, promoting the induction of p38‐CHOP and JNK signaling. Both pathways enhance macrophage apoptosis and promote the post‐translational degradation of ABCG1, a transporter that regulates cholesterol efflux in macrophages. Altogether, these findings reveal a major role for hematopoietic miR‐21 in atherogenesis.https://doi.org/10.15252/emmm.201607492apoptosisatherosclerosismacrophage polarizationmiRNA
spellingShingle Alberto Canfrán‐Duque
Noemi Rotllan
Xinbo Zhang
Marta Fernández‐Fuertes
Cristina Ramírez‐Hidalgo
Elisa Araldi
Lidia Daimiel
Rebeca Busto
Carlos Fernández‐Hernando
Yajaira Suárez
Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
EMBO Molecular Medicine
apoptosis
atherosclerosis
macrophage polarization
miRNA
title Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
title_full Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
title_fullStr Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
title_full_unstemmed Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
title_short Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
title_sort macrophage deficiency of mir 21 promotes apoptosis plaque necrosis and vascular inflammation during atherogenesis
topic apoptosis
atherosclerosis
macrophage polarization
miRNA
url https://doi.org/10.15252/emmm.201607492
work_keys_str_mv AT albertocanfranduque macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT noemirotllan macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT xinbozhang macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT martafernandezfuertes macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT cristinaramirezhidalgo macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT elisaaraldi macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT lidiadaimiel macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT rebecabusto macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT carlosfernandezhernando macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis
AT yajairasuarez macrophagedeficiencyofmir21promotesapoptosisplaquenecrosisandvascularinflammationduringatherogenesis